82.385
USD
-1.36
(-1.62%)
Post Trading·82.380USD-0.005(-0.01%)
Fair value76.47Plus+8%51Price 82.39119
Q4 FY2026 · Earnings report
EPS estimate 1.55Revenue estimate 5.92B
Q4 FY2026 · Earnings report
EPS estimate 1.55Revenue estimate 5.92B
GE HealthCare Technologies market capWhat is market capitalization? Market cap is what the stock market values a whole company at: its share price times the number of its shares outstanding.
GE HealthCare Technologies's market cap is 37.25B USD: 452,137,820 shares outstanding at today's price of 82.39.
- Today
- 37.25B
- Average, 5 years
- 34.71B
- Low, 5 years
- 25.43B
- High, 5 years
- 42.86B
Market cap = price × shares outstanding = 82.39 × 452.14M = 37.25B
Each day's closing price times the shares outstanding in the last 10-Q or 10-K filed by then (the quarter's basic share count, adjusted for splits); from the latest count on, the shares outstanding now.
Market cap by year and by quarter
| Fiscal year | Period ending | Market cap |
|---|---|---|
| Today | 37.25B | |
| FY2025 | 31 Dec 2025 | 37.44B |
| FY2024 | 31 Dec 2024 | 35.65B |
| FY2023 | 31 Dec 2023 | 35.18B |
| FY2022 | 31 Dec 2022 | 26.50B |
| FY2021 | 31 Dec 2021 | 27.28B |
| FY2020 | 31 Dec 2020 | 27.28B |
| FY2019 | 31 Dec 2019 | 27.28B |
| Quarter | Period ending | Market cap |
|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 29.55B |
| Q2 FY2026 | 30 Jun 2026 | 29.00B |
| Q1 FY2026 | 31 Mar 2026 | 32.46B |
| Q4 FY2025 | 31 Dec 2025 | 37.44B |
| Q3 FY2025 | 30 Sept 2025 | 34.25B |
| Q2 FY2025 | 30 Jun 2025 | 33.85B |
| Q1 FY2025 | 31 Mar 2025 | 36.88B |
| Q4 FY2024 | 31 Dec 2024 | 35.73B |
| Q3 FY2024 | 30 Sept 2024 | 42.89B |
| Q2 FY2024 | 30 Jun 2024 | 34.85B |
| Q1 FY2024 | 31 Mar 2024 | 40.83B |
| Q4 FY2023 | 31 Dec 2023 | 35.18B |
| Q3 FY2023 | 30 Sept 2023 | 30.96B |
| Q2 FY2023 | 30 Jun 2023 | 36.96B |
| Q1 FY2023 | 31 Mar 2023 | 37.24B |
| Q4 FY2022 | 31 Dec 2022 | 26.50B |
| Q3 FY2022 | 30 Sept 2022 | 27.24B |
| Q2 FY2022 | 30 Jun 2022 | 27.24B |
| Q1 FY2022 | 31 Mar 2022 | 27.24B |
| Q4 FY2021 | 31 Dec 2021 | 27.28B |
| Q3 FY2021 | 30 Sept 2021 | 27.28B |
| Q2 FY2021 | 30 Jun 2021 | 27.28B |
| Q1 FY2021 | 31 Mar 2021 | 27.28B |
See also:P/E ratio,P/S ratio,Dividend yield,ROE (return on equity),Debt to equity,Current ratio,All ratios
Common questions about GE HealthCare Technologies's market cap
Source: Financial Modeling Prep
